LARS - Low Anterior Resection Syndrome Clinical Trials

6 recruiting

LARS - Low Anterior Resection Syndrome Trials at a Glance

6 actively recruiting trials for lars - low anterior resection syndrome are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Leuven, Besançon, and Bordeaux. Lead sponsors running lars - low anterior resection syndrome studies include KU Leuven, F. D. Roosevelt University Hospital, and Qufora A/S.

Browse lars - low anterior resection syndrome trials by phase

Treatments under study

About LARS - Low Anterior Resection Syndrome Clinical Trials

Looking for clinical trials for LARS - Low Anterior Resection Syndrome? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new LARS - Low Anterior Resection Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about LARS - Low Anterior Resection Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary

Rectal CancerLARS - Low Anterior Resection Syndrome
KU Leuven158 enrolled1 locationNCT06274190
Recruiting
Not Applicable

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients_contributing Factors (Treatable)

Rectal CancerLARS - Low Anterior Resection SyndromeActive Surveillance
KU Leuven150 enrolled1 locationNCT06914245
Recruiting
Not Applicable

ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens

Rectal AdenocarcinomaLARS - Low Anterior Resection SyndromeLow Anterior Resection+2 more
University Hospital, Antwerp100 enrolled1 locationNCT07339904
Recruiting

A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora® IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients

Rectal CancerLARS - Low Anterior Resection SyndromeGastroenterology
Qufora A/S78 enrolled9 locationsNCT06923150
Recruiting
Not Applicable

Effectiveness of Pelvic Floor Exercise to Prevent LARS (Low Anterior Resection Syndrome)

Rectal CancerPreventionPelvic Floor Disorders+2 more
F. D. Roosevelt University Hospital50 enrolled1 locationNCT06519006
Recruiting
Not Applicable

5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)

LARS - Low Anterior Resection Syndrome
Seoul National University Hospital212 enrolled1 locationNCT05577845